-->
Home > G. Tumoral pathology > infantile hemangioma

| PubMed | eMedicine | OMIM | Google | Google images | Yahoo images | YouTube |

  • Printer friendly version

infantile hemangioma

Infantile hemangioma Infantile hemangioma Infantile hemangioma GLUT1 positivity in nfantile hemangioma Infantile hemangioma Infantile hemangioma Infantile hemangioma Infantile hemangioma Infantile hemangioma Infantile hemangioma Infantile hemangioma Infantile hemangioma Infantile hemangioma Infantile hemangioma Infantile hemangioma Infantile hemangioma

CLINICAL: The typical infantile hemangioma appears postnataly, grows quickly, and regresses gradually in the first few years of life. Approximately one third of IH are present at birth.

Infantile hemangiomas progress through 3 stages: proliferative, involuting, and involuted. The proliferative phase is characterized by clinical growth. Once hemangiomas reach their maximum size, they begin to regress or involute. Histologically, this stage is characterized by endothelial apoptosis. Finally, the involuted stage of the hemangioma occurs when the original lesion is replaced by a connective tissue remnant. In contrast to hemangiomas, vascular malformations do not involute but continue to enlarge as the patient grows.

HISTOPATHOLOGY: these tumors are highly cellular, involving the dermis, often with extension into the subcutis. The tumor has a lobular architecture and plump endothelial cells. The latter cells express glut-1 antigens throughout the life of this tumor.

Synopsis

- lobular architecture

Developmental phases:

- proliferative phase
- involutive phase
- end-stage

Localization

- cutaneous infantile hemangioma
- extra-cutaneous GLUT1+ infantile hemangioma

Variants

- multiple infantile hemangioma (16880251)
- reticular infantile hemangioma (17845155)

Associations

- type 2 infantile hepatic hemangioendothelioma (16880251)

Differential diagnosis

- congenital hemangiomas

  • RICH (rapidly involuting congenital hemangioma)
  • NICH (non-involuting congenital hemangioma)

- vascular malformations

Immunochemsitry

- WT1+
- GLUT1+ (16230568)

Tumors GLUT1 WT1
infantile hemangioma + +
vascular malformation - -

Predisposition

- Beckwith-Wiedemann syndrome (15509684)
- familial predisposition at locus 5q31-33

Molecular biology

- monoclonality

RETURN TO: vascular tumors

References

- Lawley LP, Cerimele F, Weiss SW, North P, Cohen C, Kozakewich HP, Mulliken JB, Arbiser JL. Expression of Wilms tumor 1 gene distinguishes vascular malformations from proliferative endothelial lesions. Arch Dermatol. 2005 Oct;141(10):1297-300. PMID: 16230568

- Timar J, Meszaros L, Orosz Z, Albini A, Raso E. WT1 expression in angiogenic tumours of the skin. Histopathology. 2005 Jul;47(1):67-73. PMID: 15982325

- Dadras SS, North PE, Bertoncini J, Mihm MC, Detmar M. Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol. 2004 Sep;17(9):1068-79. PMID: 15143338